MetLife Investment Management’s Lemonade LMND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Buy
41,863
+8,133
+24% +$476K 0.01% 966
2026
Q1
$2.11M Buy
33,730
+366
+1% +$25.3K 0.01% 1027
2025
Q4
$2.37M Buy
33,364
+1,008
+3% +$67.7K 0.01% 993
2025
Q3
$1.73M Sell
32,356
-872
-3% -$42.5K 0.01% 1157
2025
Q2
$1.46M Buy
33,228
+2,629
+9% +$87.6K 0.01% 1138
2025
Q1
$962K Sell
30,599
-469
-2% -$16.1K 0.01% 1390
2024
Q4
$1.14M Buy
31,068
+1,391
+5% +$44.4K 0.01% 1343
2024
Q3
$489K Hold
29,677
﹤0.01% 1795
2024
Q2
$490K Buy
29,677
+2,817
+10% +$47K ﹤0.01% 1723
2024
Q1
$441K Hold
26,860
﹤0.01% 1746
2023
Q4
$433K Hold
26,860
﹤0.01% 1776
2023
Q3
$312K Hold
26,860
﹤0.01% 1922
2023
Q2
$453K Buy
26,860
+2,516
+10% +$39.4K ﹤0.01% 1762
2023
Q1
$347K Hold
24,344
﹤0.01% 1871
2022
Q4
$333K Hold
24,344
﹤0.01% 1904
2022
Q3
$516K Buy
24,344
+3,281
+16% +$74.6K ﹤0.01% 1614
2022
Q2
$385K Buy
21,063
+20,122
+2,138% +$424K ﹤0.01% 1845
2022
Q1
$24.8K Buy
+941
New +$26.6K ﹤0.01% 2700

Other funds holding LMND

MetLife Investment Management's LMND Position: Q2 2026 in Review

MetLife Investment Management increased its Lemonade (LMND) stake by 24% in Q2 2026, buying an estimated $476K and bringing the position to 41,863 shares worth $2.72M. The position accounts for 0.01% of the portfolio, ranked #966.

MetLife Investment Management first reported a position in LMND in Q1 2022 and has held it in 18 quarters since. 336 funds tracked by Wall St. Rank hold LMND as of Q2 2026.

  • MetLife Investment Management held 41,863 shares of Lemonade worth $2.72M as of Q2 2026.
  • MetLife Investment Management bought 8,133 Lemonade shares in Q2 2026, an estimated $476K.
  • Lemonade made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #966 holding.
  • MetLife Investment Management first reported a position in Lemonade in Q1 2022 and has held it in 18 quarters since.
  • 336 funds tracked by Wall St. Rank held Lemonade as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.